Ameritas Investment Partners’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $18.1K | Hold |
6,984
| – | – | ﹤0.01% | 2807 |
|
|
2026
Q1 | $21.4K | Hold |
6,984
| – | – | ﹤0.01% | 2560 |
|
|
2025
Q4 | $24.9K | Hold |
6,984
| – | – | ﹤0.01% | 2528 |
|
|
2025
Q3 | $62.2K | Sell |
6,984
-1,551
| -18% | -$15.7K | ﹤0.01% | 1977 |
|
|
2025
Q2 | $78.7K | Buy |
8,535
+1,559
| +22% | +$13.3K | ﹤0.01% | 1909 |
|
|
2025
Q1 | $59.9K | Hold |
6,976
| – | – | ﹤0.01% | 2005 |
|
|
2024
Q4 | $74.9K | Hold |
6,976
| – | – | ﹤0.01% | 1953 |
|
|
2024
Q3 | $39.6K | Hold |
6,976
| – | – | ﹤0.01% | 2330 |
|
|
2024
Q2 | $29.4K | Hold |
6,976
| – | – | ﹤0.01% | 2432 |
|
|
2024
Q1 | $35.5K | Hold |
6,976
| – | – | ﹤0.01% | 2315 |
|
|
2023
Q4 | $64.9K | Hold |
6,976
| – | – | ﹤0.01% | 2014 |
|
|
2023
Q3 | $45.7K | Buy |
6,976
+2,110
| +43% | +$16.8K | ﹤0.01% | 2156 |
|
|
2023
Q2 | $39.6K | Hold |
4,866
| – | – | ﹤0.01% | 2186 |
|
|
2023
Q1 | $41.7K | Hold |
4,866
| – | – | ﹤0.01% | 2085 |
|
|
2022
Q4 | $50.9K | Hold |
4,866
| – | – | ﹤0.01% | 2037 |
|
|
2022
Q3 | $50K | Hold |
4,866
| – | – | ﹤0.01% | 1974 |
|
|
2022
Q2 | $48K | Hold |
4,866
| – | – | ﹤0.01% | 2002 |
|
|
2022
Q1 | $60K | Hold |
4,866
| – | – | ﹤0.01% | 1949 |
|
|
2021
Q4 | $84K | Hold |
4,866
| – | – | ﹤0.01% | 1787 |
|
|
2021
Q3 | $87K | Hold |
4,866
| – | – | ﹤0.01% | 1771 |
|
|
2021
Q2 | $111K | Buy |
4,866
+429
| +10% | +$6.35K | ﹤0.01% | 1660 |
|
|
2021
Q1 | $66K | Buy |
4,437
+650
| +17% | +$7.1K | ﹤0.01% | 1914 |
|
|
2020
Q4 | $20K | Hold |
3,787
| – | – | ﹤0.01% | 2464 |
|
|
2020
Q3 | $17K | Hold |
3,787
| – | – | ﹤0.01% | 2457 |
|
|
2020
Q2 | $19K | Hold |
3,787
| – | – | ﹤0.01% | 2361 |
|
|
2020
Q1 | $12K | Hold |
3,787
| – | – | ﹤0.01% | 2432 |
|
|
2019
Q4 | $10K | Hold |
3,787
| – | – | ﹤0.01% | 2731 |
|
|
2019
Q3 | $12K | Hold |
3,787
| – | – | ﹤0.01% | 2645 |
|
|
2019
Q2 | $13K | Buy |
+3,787
| New | +$11.8K | ﹤0.01% | 2676 |
|
|
2018
Q2 | – | Sell |
-2,544
| Closed | -$7K | – | 3004 |
|
|
2018
Q1 | $7K | Hold |
2,544
| – | – | ﹤0.01% | 2806 |
|
|
2017
Q4 | $8K | Hold |
2,544
| – | – | ﹤0.01% | 2808 |
|
|
2017
Q3 | $11K | Hold |
2,544
| – | – | ﹤0.01% | 2728 |
|
|
2017
Q2 | $14K | Hold |
2,544
| – | – | ﹤0.01% | 2648 |
|
|
2017
Q1 | $15K | Buy |
+2,544
| New | +$13.1K | ﹤0.01% | 2544 |
|
Other funds holding AVXL
SF
Ameritas Investment Partners's AVXL Position: Q2 2026 in Review
Ameritas Investment Partners held its Anavex Life Sciences (AVXL) position steady in Q2 2026 at 6,984 shares worth $18.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2807.
Ameritas Investment Partners first reported a position in AVXL in Q1 2017 and has held it in 34 quarters since. The position peaked at $111K in Q2 2021. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.
- Ameritas Investment Partners held 6,984 shares of Anavex Life Sciences worth $18.1K as of Q2 2026.
- Ameritas Investment Partners left its Anavex Life Sciences share count unchanged in Q2 2026.
- Anavex Life Sciences made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #2807 holding.
- Ameritas Investment Partners first reported a position in Anavex Life Sciences in Q1 2017 and has held it in 34 quarters since.
- Ameritas Investment Partners's Anavex Life Sciences position peaked at $111K in Q2 2021.
- 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.
Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.